College Hill adds six new clients in 2013

College Hill has announced it has continued to expand its portfolio of clients in 2013, with six new additions from Europe and Australia over the last three months.

The company revealed it has welcomed customers for a range of new projects, including branding and public relations.

In Europe, the organisation has been commissioned by France-based Nanobiotix, German firm AiCuris and Austrian company Hookipa Biotech.

These partnerships will see College Hill take on a range of tasks including the support of financial and corporate communications across the globe.

The Australian deals feature collaborations with ASX-listed firm Antisense Therapeutics, along with Medical Research Commercialisation Fund firms Polyactiva and Helmedix.

Sue Charles, managing partner at College Hill Life Sciences, said: "Many commentators have suggested that 2013 will be a good year for biotech companies and we are delighted to have been chosen by these new clients to support them in using brand building and business communication."